Sami Aifa - Search Results

Year	Number of Results
2002	1
2005	1
2006	2
2008	1
2010	2
2011	2
2012	2
2013	3
2014	4
2015	2
2016	1
2017	2
2019	5
2020	3
2021	2
2022	5
2023	2
2024	3

1

Amri R, Chelly A, Ayedi M, Rebaii MA, Aifa S, Masmoudi S, Keskes H. Amri R, et al. Among authors: aifa s. Bone Joint Res. 2024 Apr 1;13(4):136. doi: 10.1302/2046-3758.134.BJR-2024-00002. Bone Joint Res. 2024. PMID: 38555954 Free PMC article. No abstract available.

2

Monoclonal antibodies as cancer therapeutics.

Elloumi J, Jellali K, Jemel I, Aifa S. Elloumi J, et al. Among authors: aifa s. Recent Pat Biotechnol. 2012 Apr;6(1):45-56. doi: 10.2174/187220812799789190. Recent Pat Biotechnol. 2012. PMID: 22420881 Review.

3

Cumin (Cuminum cyminum L.) from traditional uses to potential biomedical applications.

Mnif S, Aifa S. Mnif S, et al. Among authors: aifa s. Chem Biodivers. 2015 May;12(5):733-42. doi: 10.1002/cbdv.201400305. Chem Biodivers. 2015. PMID: 26010662 Review.

4

Chemical alternative for cell identification and cross-contamination detection.

Msalbi D, Elloumi-Mseddi J, Hakim B, Sahli E, Aifa S. Msalbi D, et al. Among authors: aifa s. 3 Biotech. 2022 Mar;12(3):78. doi: 10.1007/s13205-022-03144-z. Epub 2022 Feb 25. 3 Biotech. 2022. PMID: 35251881 Free PMC article.

5

ErbB antagonists patenting: "playing chess with cancer".

Aifa S, Rebai A. Aifa S, et al. Recent Pat Biotechnol. 2008;2(3):181-7. doi: 10.2174/187220808786240980. Recent Pat Biotechnol. 2008. PMID: 19075865 Review.

6

Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties.

Choura E, Elghali F, Bernard PJ, Msalbi D, Marco-Contelles J, Aifa S, Ismaili L, Chabchoub F. Choura E, et al. Among authors: aifa s. Molecules. 2022 Nov 15;27(22):7878. doi: 10.3390/molecules27227878. Molecules. 2022. PMID: 36431976 Free PMC article.

7

Anti-Diarrheal Drug Repositioning in Tumour Cell Cytotoxicity.

Elloumi-Mseddi J, Msalbi D, Fakhfakh R, Aifa S. Elloumi-Mseddi J, et al. Among authors: aifa s. Anticancer Agents Med Chem. 2019;19(8):1037-1047. doi: 10.2174/1871520619666190118120030. Anticancer Agents Med Chem. 2019. PMID: 30657046

8

The offer of chemistry to targeted therapy in cancer.

Jemel I, Jellali K, Elloumi J, Aifa S. Jemel I, et al. Among authors: aifa s. Recent Pat Biotechnol. 2011 Dec;5(3):174-82. doi: 10.2174/187220811797579079. Recent Pat Biotechnol. 2011. PMID: 22360466 Review.

9

Three Component One-Pot Synthesis and Antiproliferative Activity of New [1,2,4]Triazolo[4,3-a]pyrimidines.

Ben Hassen M, Msalbi D, Jismy B, Elghali F, Aifa S, Allouchi H, Abarbri M, Chabchoub F. Ben Hassen M, et al. Among authors: aifa s. Molecules. 2023 May 5;28(9):3917. doi: 10.3390/molecules28093917. Molecules. 2023. PMID: 37175327 Free PMC article.

10

Molecular insights into MYO3A kinase domain variants explain variability in both severity and progression of DFNB30 hearing impairment.

Souissi A, Abdelmalek Driss D, Chakchouk I, Ben Said M, Ben Ayed I, Mosrati MA, Elloumi I, Tlili A, Aifa S, Masmoudi S. Souissi A, et al. Among authors: aifa s. J Biomol Struct Dyn. 2022;40(21):10940-10951. doi: 10.1080/07391102.2021.1953600. Epub 2021 Aug 23. J Biomol Struct Dyn. 2022. PMID: 34423747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year